TOPICS

Category: Acne

Sarecycline and the Narrow-spectrum Tetracycline Concept: Currently Available Data and Potential Clinical Relevance in Dermatology

J Clin Aesthet Dermatol. 2020;13(10):45–48 by James Q. Del Rosso, DO, FAAD, FAOCD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada, is with Thomas Dermatology in Las Vegas, Nevada, and is an adjunct clinical professor of dermatology at Touro University Nevada in Henderson, Nevada. FUNDING: No funding was provided

CONTINUE READING »

A Split-face, Controlled Study to Assess the Compatibility of Tretinoin 0.05% Acne Lotion with Facial Foundation Makeup

J Clin Aesthet Dermatol. 2020;13(10) by Neal Bhatia, MD; Leon H. Kircik MD; Ava Shamban, MD; Varsha Bhatt, PhD; Radhakrishnan Pillai, PhD; and Eric Guenin, PharmD, PhD, MPH Dr. Bhatia is with Therapeutics Clinical Research in San Diego, California. Dr. Kircik is with Indiana University School of Medicine in Indianapolis, IN, Physicians Skin Care, PLLC,

CONTINUE READING »

Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study

J Clin Aesthet Dermatol. 2020;13(9):15–20 by Andrea L. Zaenglein, MD; Jeanett Segal, MD; Charles Darby, MSc; and James Q. Del Rosso, DO Dr. Zaenglein is with Departments of Dermatology and Pediatrics at Penn State College of Medicine, Hershey Medical Center in Hershey, Pennsylvania. Dr. Segal is with Sun Pharmaceutical Industries, Inc., in Princeton, New Jersey.

CONTINUE READING »

Oral Antibiotic Treatment Options for Acne Vulgaris

J Clin Aesthet Dermatol. 2020;13(9):26–32 by Hilary Baldwin, MD Dr. Baldwin is the Medical Director of the Acne Treatment and Research Center in Brooklyn, New York and is with Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey. ABSTRACT: Acne vulgaris is the most common dermatological disease in the United States, affecting up

CONTINUE READING »